138 related articles for article (PubMed ID: 32392924)
21. MiR-125b regulates the proliferation and metastasis of triple negative breast cancer cells via the Wnt/β-catenin pathway and EMT.
Nie J; Jiang HC; Zhou YC; Jiang B; He WJ; Wang YF; Dong J
Biosci Biotechnol Biochem; 2019 Jun; 83(6):1062-1071. PubMed ID: 30950326
[TBL] [Abstract][Full Text] [Related]
22. In vivo β-catenin attenuation by the integrin α5-targeting nano-delivery strategy suppresses triple negative breast cancer stemness and metastasis.
Li Y; Xiao Y; Lin HP; Reichel D; Bae Y; Lee EY; Jiang Y; Huang X; Yang C; Wang Z
Biomaterials; 2019 Jan; 188():160-172. PubMed ID: 30352320
[TBL] [Abstract][Full Text] [Related]
23. A novel recombinant human Frizzled-7 protein exhibits anti-tumor activity against triple negative breast cancer via abating Wnt/β-catenin pathway.
Xie W; Zhang Y; He Y; Zhang K; Wan G; Huang Y; Zhou Z; Huang G; Wang J
Int J Biochem Cell Biol; 2018 Oct; 103():45-55. PubMed ID: 30096373
[TBL] [Abstract][Full Text] [Related]
24. Reduced lncRNA Aim enhances the malignant invasion of triple-negative breast cancer cells mainly by activating Wnt/β-catenin/mTOR/PI3K signaling.
Liu L; Yu D; Shi H; Li J; Meng L
Pharmazie; 2017 Oct; 72(10):599-603. PubMed ID: 29441885
[TBL] [Abstract][Full Text] [Related]
25. Interaction Between Beta-Catenin and EGFR Expression by Immunohistochemistry Identifies Prognostic Subgroups in Early High-risk Triple-negative Breast Cancer.
Lakis S; Dimoudis S; Kotoula V; Alexopoulou Z; Kostopoulos I; Koletsa T; Bobos M; Timotheadou E; Papaspirou I; Efstratiou I; Aravantinos G; Karavasilis V; Zagouri F; Gogas H; Razis E; Pentheroudakis G; Christodoulou C; Pectasides D; Fountzilas G
Anticancer Res; 2016 May; 36(5):2365-78. PubMed ID: 27127145
[TBL] [Abstract][Full Text] [Related]
26. Cancer-Associated Fibroblasts Autophagy Enhances Progression of Triple-Negative Breast Cancer Cells.
Wang M; Zhang J; Huang Y; Ji S; Shao G; Feng S; Chen D; Zhao K; Wang Z; Wu A
Med Sci Monit; 2017 Aug; 23():3904-3912. PubMed ID: 28802099
[TBL] [Abstract][Full Text] [Related]
27. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer.
Cheng G; Fan X; Hao M; Wang J; Zhou X; Sun X
Mol Cancer; 2016 Apr; 15(1):30. PubMed ID: 27130446
[TBL] [Abstract][Full Text] [Related]
28. Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer.
Lin CC; Lo MC; Moody R; Jiang H; Harouaka R; Stevers N; Tinsley S; Gasparyan M; Wicha M; Sun D
Cancer Lett; 2018 Dec; 438():165-173. PubMed ID: 30227220
[TBL] [Abstract][Full Text] [Related]
29. MAGE-A is frequently expressed in triple negative breast cancer and associated with epithelial-mesenchymal transition.
Wang H; Sang M; Geng C; Liu F; Gu L; Shan B
Neoplasma; 2016; 63(1):44-56. PubMed ID: 26639233
[TBL] [Abstract][Full Text] [Related]
30. Shikonin inhibits triple-negative breast cancer-cell metastasis by reversing the epithelial-to-mesenchymal transition via glycogen synthase kinase 3β-regulated suppression of β-catenin signaling.
Chen Y; Chen ZY; Chen L; Zhang JY; Fu LY; Tao L; Zhang Y; Hu XX; Shen XC
Biochem Pharmacol; 2019 Aug; 166():33-45. PubMed ID: 31071331
[TBL] [Abstract][Full Text] [Related]
31. [Effect of overexpression of integrin β2 on clinical prognosis in triple negative breast cancer].
Puerkaiti P; Fan JJ; Ma BL
Zhonghua Yi Xue Za Zhi; 2020 Aug; 100(30):2358-2362. PubMed ID: 32791811
[No Abstract] [Full Text] [Related]
32. Cadherin 11 Inhibition Downregulates β-catenin, Deactivates the Canonical WNT Signalling Pathway and Suppresses the Cancer Stem Cell-Like Phenotype of Triple Negative Breast Cancer.
Satriyo PB; Bamodu OA; Chen JH; Aryandono T; Haryana SM; Yeh CT; Chao TY
J Clin Med; 2019 Jan; 8(2):. PubMed ID: 30691241
[TBL] [Abstract][Full Text] [Related]
33. Inhibiting β-catenin disables nucleolar functions in triple-negative breast cancer.
Weeks SE; Kammerud SC; Metge BJ; AlSheikh HA; Schneider DA; Chen D; Wei S; Mobley JA; Ojesina AI; Shevde LA; Samant RS
Cell Death Dis; 2021 Mar; 12(3):242. PubMed ID: 33664239
[TBL] [Abstract][Full Text] [Related]
34. Circ-ITCH regulates triple-negative breast cancer progression through the Wnt/β-catenin pathway.
Wang ST; Liu LB; Li XM; Wang YF; Xie PJ; Li Q; Wang R; Wei Q; Kang YH; Meng R; Feng XH
Neoplasma; 2019 Mar; 66(2):232-239. PubMed ID: 30509108
[TBL] [Abstract][Full Text] [Related]
35. Pomegranate peel extract inhibits expression of β-catenin, epithelial mesenchymal transition, and metastasis in triple negative breast cancer cells.
Bagheri M; Fazli M; Saeednia S; Kor A; Ahmadiankia N
Cell Mol Biol (Noisy-le-grand); 2018 May; 64(7):86-91. PubMed ID: 29974851
[TBL] [Abstract][Full Text] [Related]
36. miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer.
Li HY; Liang JL; Kuo YL; Lee HH; Calkins MJ; Chang HT; Lin FC; Chen YC; Hsu TI; Hsiao M; Ger LP; Lu PJ
Breast Cancer Res; 2017 Dec; 19(1):133. PubMed ID: 29258605
[TBL] [Abstract][Full Text] [Related]
37. Frequent inactivation of MCC/CTNNBIP1 and overexpression of phospho-beta-catenin(Y654) are associated with breast carcinoma: Clinical and prognostic significance.
Mukherjee N; Dasgupta H; Bhattacharya R; Pal D; Roy R; Islam S; Alam N; Biswas J; Roy A; Roychoudhury S; Panda CK
Biochim Biophys Acta; 2016 Sep; 1862(9):1472-84. PubMed ID: 27208794
[TBL] [Abstract][Full Text] [Related]
38. Interference KRT17 reverses doxorubicin resistance in triple-negative breast cancer cells by Wnt/β-catenin signaling pathway.
Wu L; Ding W; Wang X; Li X; Yang J
Genes Genomics; 2023 Oct; 45(10):1329-1338. PubMed ID: 37634232
[TBL] [Abstract][Full Text] [Related]
39. DAB2IP attenuates chemoresistance of triple-negative breast cancer through sequestration of RAC1 to prevent β-catenin nuclear accumulation.
Xiong Z; Yang L; Li N; Fu J; Liu P; Sun P; Wei W; Xie X
Clin Transl Med; 2022 Dec; 12(12):e1133. PubMed ID: 36536485
[TBL] [Abstract][Full Text] [Related]
40. A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling.
Wang DY; Gendoo DMA; Ben-David Y; Woodgett JR; Zacksenhaus E
Breast Cancer Res; 2019 Jan; 21(1):18. PubMed ID: 30704524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]